Accretion Pharmaceuticals IPO is to open on May 16. Accretion Pharmaceuticals is a SME IPO to raise ā¹29.75 crores via IPO. The Accretion Pharmaceuticals IPO price band is fixed at ā¹96 to ā¹101 with a market lot of 1200 Shares.
Accretion Pharmaceuticals Limited, established in 2012, is one of the leading pharmaceutical companies involved in the manufacturing and marketing of Tablets, Capsules, and other healthcare products. Other than manufacturing its products for sale, the company also manufactures various pharmaceutical products for other brands through license agreements or contract manufacturing. The company has achieved various certifications, showcasing its commitment to the quality and environmental standards. The manufacturing facility is situated in Ahemdabad, Sanand, Gujarat. Accretion Pharmaceutical has established its presence in more than 20 countries by expanding its business in various regions such as Africa, Southeast Asia, and the Middle East. The company comprises a total of 83 employees, including 4 Executive Directors, as of January 2025.
Accretion Pharmaceuticals IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Kostak | Subject to |
| 22 May | ā¹- | – | ā¹- | ā¹- |
| 21 May | ā¹- | – | ā¹- | ā¹- |
| 20 May | ā¹- | – | ā¹- | ā¹- |
| 19 May | ā¹0 | – | ā¹- | ā¹- |
| 17 May | ā¹0 |  | ā¹- | ā¹- |
| 16 May | ā¹5 | | ā¹- | ā¹4,500 |
| 15 May | ā¹10 | | ā¹- | ā¹9,000 |
| 14 May | ā¹18 |  | ā¹- | ā¹16,400 |
| 13 May | ā¹8 | | ā¹- | ā¹7,300 |
| 12 May | ā¹- | – | ā¹- | ā¹- |
| 10 May | ā¹- | – | ā¹- | ā¹- |
| 9 May | ā¹- | – | ā¹- | ā¹- |
| 8 May | ā¹- | – | ā¹- | ā¹- |
| 7 May | ā¹- | – | ā¹- | ā¹- |
Accretion Pharmaceuticals IPO Details
| IPO Open Date: | May 14, 2025 |
| IPO Close Date: | May 16, 2025 |
| Face Value: | ā¹10 Per Equity Share |
| IPO Price Band: | ā¹96 to ā¹101 Per Share |
| Issue Size: | Approx ā¹29.75 Crores |
| Fresh Issue: | Approx ā¹29.75 Crores |
| Issue Type: | Book Built Issue |
| IPO Listing: | NSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Accretion Pharmaceuticals IPO Dates
| PO Open Date: | May 14, 2025 |
| IPO Close Date: | May 16, 2025 |
| Basis of Allotment: | May 19, 2025 |
| Refunds: | May 20, 2025 |
| Credit to Demat Account: | May 20, 2025 |
| IPO Listing Date: | May 21, 2025 |
Accretion Pharmaceuticals IPO GMP aka Grey Market Premium FAQs:
What is Accretion Pharmaceuticals IPO GMP Today?
What is Accretion Pharmaceuticals IPO Kostak Rate Today?
What is Accretion Pharmaceuticals IPO Subject to Sauda Today?
What is Accretion Pharmaceuticals IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Accretion Pharmaceuticals IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
